Recruiting PHASE3 INTERVENTIONAL 2-arm NCT05335252

Dronabinol After Arthroscopic Surgery

Dronabinol for the Treatment of Postoperative Pain After Arthroscopic Surgery: a Pilot Randomized Trial

Sponsor: Northwestern University

Conditions Chondral Injury of Left Knee Chondral Injury of Right Knee Knee Injuries Knee Ligament Injury Knee Osteoarthritis Loose Body Knee Meniscus Tear Synovitis of Knee

Interventions Dronabinol Placebo

Updated 8 times since 2022 Last updated: Apr 24, 2025 Started: Jun 28, 2022 Primary completion: Dec 31, 2026 Completion: Jun 30, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Chondral Injury of Left Knee and Chondral Injury of Right Knee, this trial is actively recruiting participants. The trial is conducted by Northwestern University and has accumulated 8 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

May 2025 — Present [monthly]

Recruiting PHASE3
Sep 2024 — May 2025 [monthly]

Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE3
Apr 2024 — Jul 2024 [monthly]

Recruiting PHASE3
May 2023 — Apr 2024 [monthly]

Recruiting PHASE3

▶ Show 3 earlier versions

Sep 2022 — May 2023 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Jun 2022 — Sep 2022 [monthly]

Not Yet Recruiting PHASE3
May 2022 — Jun 2022 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Northwestern University

Data source: Northwestern University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States